HOLMSIDE MEDICAL GROUP
142 ARMSTRONG ROAD, BENWELL, NEWCASTLE UPON TYNE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 24 | 28 | 85.7% | |
| HF 4 | 2011 | 32 | 36 | 88.9% | |
| HF 4 | 2012 | 34 | 38 | 89.5% | |
| HF 4 | 2013 | 33 | 38 | 86.8% | |
| HF004 | 2014 | 22 | 23 | 95.7% | |
| HF004 | 2015 | 23 | 23 | 100.0% | |
| HF004 | 2016 | 24 | 25 | 96.0% | |
| HF004 | 2017 | 31 | 32 | 96.9% | |
| HF004 | 2018 | 30 | 32 | 93.8% | |
| HF004 | 2019 | 42 | 44 | 95.5% | |
| HF004 | 2020 | 32 | 33 | 97.0% | |
| HF006 | 2021 | 35 | 37 | 94.6% | |
| HF006 | 2022 | 40 | 42 | 95.2% | |
| HF006 | 2023 | 45 | 47 | 95.7% |
